The Globe and Mail recently profiled Royal Bank of Canada's undisclosed investment in the country’s largest life sciences venture capital fund in two decades. Lumira is raising its fourth fund with a target of reaching US$200-million to back Canadian and U.S. drug and medical technology developers.
The Globe and Mail highlights RBC's investment in new Lumira venture fund
Previous
Previous
Flosonics Medical Closes US$14M Financing Round and Expands Board of Directors
Next
Next